Neogen Corporation (NEOG)

Neogen Corporation (NEOG) Healthcare & Pipeline Overview

Neogen Corporation provides food and animal safety solutions, offering diagnostic test kits, pharmaceuticals, and genomics testing services. With a global presence, Neogen serves food producers, animal care providers, and laboratories, addressing critical safety needs in the food supply chain and animal health industries.

What Is the Investment Thesis for NEOG?

Neogen Corporation presents a mixed investment thesis. The company's focus on the growing food and animal safety markets provides a strong foundation for long-term growth. Key value drivers include increasing regulatory scrutiny on food safety, rising demand for animal healthcare products, and the expansion of genomics testing services. However, the company's negative profit margin of -69.9% raises concerns about profitability and operational efficiency. Upcoming catalysts include potential acquisitions and partnerships to expand product offerings and market reach. Investors should closely monitor Neogen's ability to improve its financial performance and capitalize on growth opportunities within the next 2-3 years. The high beta of 1.97 indicates significant volatility, requiring careful risk management.

Based on FMP financials and quantitative analysis

NEOG Key Highlights

• Market Cap of $2.06B reflects Neogen's established position in the food and animal safety market.
• Gross Margin of 39.9% indicates moderate profitability in its core operations.
• Negative Profit Margin of -69.9% signals significant challenges in achieving overall profitability.
• Presence in both Food Safety and Animal Safety segments provides diversification and exposure to multiple growth areas.
• Global operations enhance market reach and reduce dependence on any single geographic region.

Who Are NEOG's Competitors?

NEOG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NEOG's Key Strengths?

• Comprehensive product portfolio in food and animal safety.
• Established brand reputation and customer relationships.
• Global distribution network.
• Strong focus on innovation and R&D.

What Are NEOG's Weaknesses?

• Negative profit margin.
• High beta indicating significant volatility.
• Dependence on regulatory approvals for certain products.
• Potential for product liability claims.

What Could Drive NEOG Stock Higher?

• Potential acquisitions and partnerships to expand product offerings and market reach.
• Increasing regulatory scrutiny on food safety driving demand for diagnostic solutions.
• Rising demand for animal healthcare products and genomics testing services.
• Expansion of presence in emerging markets with high growth potential.

What Are the Key Risks for NEOG?

• Financial-distress signal — its Altman Z-Score of 0.61 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-29.0%) — the business is not currently generating profit on shareholder capital.
• Intense competition from established players in the food and animal safety markets.
• Changing regulatory landscape affecting product approvals and market access.
• Economic downturn impacting customer spending on diagnostic and healthcare products.
• Emergence of new pathogens and diseases requiring rapid diagnostic solutions.
• Negative profit margin and challenges in achieving overall profitability.

What Are the Growth Opportunities for NEOG?

• Expansion of Genomics Testing Services: Neogen can capitalize on the increasing demand for genomics testing in animal breeding and disease management. The genomics market is projected to grow significantly over the next five years, driven by advancements in sequencing technologies and the need for precision animal care. By investing in R&D and expanding its genomics service offerings, Neogen can capture a larger share of this market and enhance its competitive advantage.
• Strategic Acquisitions and Partnerships: Neogen can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. The company can target smaller players with complementary technologies or market access to accelerate growth and strengthen its position in key markets. Successful integration of acquired businesses and effective collaboration with partners will be critical for realizing the full potential of this growth strategy.
• Penetration of Emerging Markets: Neogen can focus on expanding its presence in emerging markets, where demand for food and animal safety products is growing rapidly. These markets offer significant growth opportunities due to increasing consumer awareness, rising incomes, and expanding livestock production. Adapting products and services to meet local needs and establishing distribution networks will be essential for success in these markets.
• Development of Innovative Diagnostic Solutions: Neogen can invest in the development of innovative diagnostic solutions that address emerging food and animal safety challenges. This includes developing rapid and cost-effective tests for new pathogens, toxins, and diseases. By staying at the forefront of diagnostic technology, Neogen can maintain its competitive edge and capture new market opportunities.
• Enhancement of Digital and Data Analytics Capabilities: Neogen can leverage digital technologies and data analytics to improve its product offerings and customer service. This includes developing online platforms for ordering and tracking products, providing data-driven insights to customers, and using data analytics to optimize its own operations. By embracing digital transformation, Neogen can enhance its efficiency, improve customer satisfaction, and drive growth.

What Opportunities Does NEOG Have?

• Expansion of genomics testing services.
• Strategic acquisitions and partnerships.
• Penetration of emerging markets.
• Development of innovative diagnostic solutions.

What Threats Does NEOG Face?

• Intense competition from established players.
• Changing regulatory landscape.
• Economic downturn affecting customer spending.
• Emergence of new pathogens and diseases.

What Are NEOG's Competitive Advantages?

• Established brand reputation in the food and animal safety market.
• Extensive product portfolio covering a wide range of diagnostic and healthcare needs.
• Strong customer relationships with key players in the food and animal industries.
• Proprietary technologies and intellectual property in diagnostic testing and genomics.
• Global distribution network providing access to diverse markets.

What Does NEOG Do?

Neogen Corporation, founded in 1981 and headquartered in Lansing, Michigan, develops, manufactures, and markets a comprehensive range of products focused on food and animal safety. The company operates through two primary segments: Food Safety and Animal Safety. The Food Safety segment provides diagnostic test kits and related products designed to detect dangerous and unintended substances in food and animal feed. These include tests for foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, and various residues. The AccuPoint Advanced rapid sanitation test is also a key offering, detecting adenosine triphosphate (ATP) to ensure sanitation standards. This segment serves a diverse customer base, including food and feed producers, grain processors, meat and poultry processors, seafood processors, fruit and vegetable producers, dairies, laboratories, and producers of pharmaceuticals and cosmetics. The Animal Safety segment offers veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services. These products cater to the animal safety market, supporting researchers in detecting biologically active substances and maintaining sanitary conditions to mitigate bacterial, fungal, and viral hazards. Neogen's drug detection immunoassay test kits are utilized for detecting abused and therapeutic drugs in animals, drug residues in meat, and in human forensic toxicology. Neogen's commitment to innovation and quality has established it as a key player in ensuring the safety and integrity of the global food supply and animal health.

What Products and Services Does NEOG Offer?

• Develops and manufactures diagnostic test kits for food safety.
• Provides solutions for detecting pathogens, toxins, and allergens in food and feed.
• Offers veterinary instruments, pharmaceuticals, and vaccines for animal health.
• Provides genomics testing services for animal breeding and disease management.
• Markets cleaners, disinfectants, and insecticides for maintaining sanitary conditions.
• Offers drug detection immunoassay test kits for detecting abused and therapeutic drugs in animals.
• Provides products for researchers to detect biologically active substances.

How Does NEOG Make Money?

• Sells diagnostic test kits and related products to food and feed producers and processors.
• Generates revenue from the sale of veterinary instruments, pharmaceuticals, and vaccines to animal care providers.
• Offers genomics testing services to animal breeders and researchers.
• Provides sanitation and hygiene products to maintain safe environments in food production and animal care facilities.

What Industry Does NEOG Operate In?

Neogen Corporation operates in the growing food and animal safety market, driven by increasing consumer awareness, stringent regulations, and technological advancements. The food safety diagnostics market is expected to grow due to rising concerns about foodborne illnesses and the need for rapid and accurate testing solutions. The animal health market is also expanding, fueled by increasing pet ownership, livestock production, and demand for advanced veterinary care. Neogen competes with companies offering similar diagnostic and healthcare solutions, focusing on innovation and customer service to maintain its market position.

Who Are NEOG's Key Customers?

• Food and feed producers and processors
• Grain producers and processors
• Meat and poultry processors
• Veterinarians and animal care providers
• Laboratories and research institutions

ROE -29%Key Financial Metrics

Return on equity for Neogen Corporation stands at -29.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -18.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 2.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.92 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.6%, the inverse of the P/E and a quick read on earnings relative to price.

How Neogen Corporation Is Valued

Neogen Corporation carries a market capitalization of $2.06B, placing it in the mid-cap category. Relative to its peer group, NEOG's quantitative score of 21/100 is below the peer average of 64/100.

F-Score 6/9Financial Health

Neogen Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.61 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project Neogen Corporation revenue of about $857.5M for fiscal 2026, with EPS near $0.37. The estimate reflects 4 contributing analysts.

NEOG Financials

NEOG Latest News

NEOG Analyst Consensus

NEOG MoonshotScore

Latest Neogen Corporation Analysis

Neogen Corporation Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources